UK MHRA and Japan's PMDA agree on sharing confidential data on therapeutic products
This article was originally published in SRA
The UK Medicines and Healthcare products Regulatory Agency has signed a confidentiality agreement with Japan's Pharmaceuticals and Medical Devices Agency and its Pharmaceutical and Food Safety Bureau1.
You may also be interested in...
The UK’s deployment of COVID-19 vaccines has left vaccine manufacturers worried about emerging discussions on dosing strategies that may not be supported by authorized labeling or published clinical data.
Existing importers and manufacturers of certain medical devices can continue marketing their products for six months or until the Indian medtech regulator makes a final decision on their pending licensing applications.
Differences between how Australia and the EU define “central circulatory system” has resulted in different risk classification levels being assigned to some devices in the two jurisdictions.